Shyft Score
Directory quality rating
57/100
Quiet
Our take
The verdict on Amass
AI-generated
Amass aggregates scientific data across literature, patents, trials, and regulatory sources with AI-backed citation retrieval. It targets researchers and life science teams needing evidence-based decision support, though implementation scope and learning curve remain unclear from available details.
Strengths
- Consolidates 500M+ documents across four critical scientific domains in one interface
- Citation-backed answers reduce risk of unsupported claims in research workflows
- API access enables integration into existing institutional systems
- Monitoring capabilities support ongoing tracking of regulatory and patent landscapes
Limitations
- No detail on data freshness, update frequency, or lag time for newly published literature
- Unclear how AI handles conflicting evidence across large document sets or quality variance
- Significant barrier to entry for smaller teams or resource-constrained institutions
Best for: Life science companies and research teams requiring multi-source regulatory and patent intelligence
Try Amass's free tier to see if it fits your workflow.
See how Amass fits your stackBenefits
Why teams choose Amass
Consolidates 500M+ documents across four critical scientific domains in one interface
Citation-backed answers reduce risk of unsupported claims in research workflows
API access enables integration into existing institutional systems
Monitoring capabilities support ongoing tracking of regulatory and patent landscapes
About
What is Amass?
Amass is a scientific intelligence platform that consolidates over 500 million documents including literature, patents, trials, and regulatory data. It provides citation-backed answers and is used by researchers and life science companies for decision-making based on solid evidence.
Key capabilities
AI assistant
Planning tools
Monitoring capabilities
API access
Citation management
At a glance
Use cases
What you can do with Amass
Accelerate drug discovery by identifying novel drug-target interactions from 500M+ documents in minutes, reducing R&D timelines by 30% or more
Streamline regulatory submissions by extracting and summarizing critical safety data from patents and clinical trials, cutting compliance review time by 40%
Optimize clinical trial design by analyzing historical trial outcomes and patient demographics, improving enrollment success rates by 25%
Support competitive intelligence by tracking competitor patent filings and literature trends, enabling proactive strategy adjustments
Enhance literature reviews by automating citation extraction and synthesis for grant applications or peer-reviewed publications, reducing manual effort by 60%
Pricing
Amass pricing
Amass starts at Free
Starting at Free
Pricing and product details are aggregated from publicly available sources, may be outdated or inaccurate, and are not sourced from or endorsed by the vendor. Verify directly with the vendor before relying on this information. Terms
FAQs
Frequently asked questions
Common questions about Amass and its capabilities
Yes, Amass offers a free tier to get started. Paid plans start at Free. The free tier is ideal for small teams or individual users evaluating the platform.
Need help automating Amass?
Our team can help you integrate Amass with your existing tools and build custom automation workflows.
No commitment requiredResponse within 24h
Get weekly AI tool updates
Pulse delivers personalized AI tool intelligence every week. Free.
Explore
Discover more
Alternatives, related tools, and resources for Amass
Related Resources
Using Amass? See how your stack compares.
Our free scan analyzes your website, detects your tools, and shows gaps in your AI readiness.
Take free scan →